Figure 1.
Prediction of changes in IMT and FMD bei sdLDL and LDL-C.
Changes in IMT during the 2 year follow-up are shown in relation to the proportion of small, dense LDL particles at baseline (a). Changes in FMD during follow-up are shown in relation to the proportion of LDL-C levels at baseline (1B), p<0.05.
Figure 2.
Changes in HOMA2 and resistin / adiponectin levels depend on changes in the proportion of sdLDL particles.
The Proportion of patients (%) with constant or improved insulin resistance (white) or worsened insulin resistance (black) (assessed by HOMA2 during 2 years of follow-up) is shown for those patients with and those without an increase in small, dense LDL particles (2A, p<0.05). Changes (%) of resistin and adiponectin levels during the 2 years of follow-up are shown in in patients with and those without an increase in small, dense LDL particles (2B). * Significantly different from baseline, p<0.05.